These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 32194140)
1. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma. Ding C; Yi X; Wu X; Bu X; Wang D; Wu Z; Zhang G; Gu J; Kang D Cancer Lett; 2020 Jun; 479():1-12. PubMed ID: 32194140 [TBL] [Abstract][Full Text] [Related]
2. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma. Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615 [TBL] [Abstract][Full Text] [Related]
3. Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma. Geng X; Zhang Y; Lin X; Zeng Z; Hu J; Hao L; Xu J; Wang X; Wang H; Li Q Cell Death Dis; 2022 Jul; 13(7):596. PubMed ID: 35817771 [TBL] [Abstract][Full Text] [Related]
4. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma. Si J; Li W; Li X; Cao L; Chen Z; Jiang Z Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683 [TBL] [Abstract][Full Text] [Related]
5. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ Han C; Wang S; Wang H; Zhang J Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821 [No Abstract] [Full Text] [Related]
6. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis. Deng Y; Zhu H; Xiao L; Liu C; Meng X Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781 [TBL] [Abstract][Full Text] [Related]
7. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
8. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7. Wang J; Li T; Wang B Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294. Hua L; Huang L; Zhang X; Feng H J Biosci; 2020; 45():. PubMed ID: 32975228 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression. Wu Y; Yao Y; Yun Y; Wang M; Zhu R Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409725 [TBL] [Abstract][Full Text] [Related]
11. Exosome-Mediated Transfer of circ- Li G; Lan Q Cancer Biother Radiopharm; 2023 Feb; 38(1):62-73. PubMed ID: 34762494 [No Abstract] [Full Text] [Related]
12. Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p. Li H; Liu Q; Chen Z; Wu M; Zhang C; Su J; Li Y; Zhang C Cell Death Dis; 2021 Mar; 12(3):252. PubMed ID: 33674567 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H; Cui X Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501 [No Abstract] [Full Text] [Related]
14. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis. Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501 [TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma. Li X; Wang N; Leng H; Yuan H; Xu L Metab Brain Dis; 2022 Dec; 37(8):2979-2993. PubMed ID: 36301458 [TBL] [Abstract][Full Text] [Related]
16. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935 [TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas. Wei QT; Liu BY; Ji HY; Lan YF; Tang WH; Zhou J; Zhong XY; Lian CL; Huang QZ; Wang CY; Xu YM; Guo HB Mol Ther Oncolytics; 2021 Sep; 22():114-128. PubMed ID: 34514093 [TBL] [Abstract][Full Text] [Related]
18. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
19. LncRNA-XIST interacts with Du P; Zhao H; Peng R; Liu Q; Yuan J; Peng G; Liao Y Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831025 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]